Bookmark
Forward
Explore Literature Results
Explore Clinical Trials Results
QuickView for CDK6 (gene)
Most Relevant Literature
- Non-canonical CDK6 activity promotes cilia disassembly by suppressing axoneme polyglutamylation.
- CDK6 inhibits de novo lipogenesis in white adipose tissues but not in the liver.
- A disproportionality analysis of CDK4/6 inhibitors in the FDA Adverse Event Reporting System (FAERS)…
- Kinase-inactivated CDK6 preserves the long-term functionality of adult hematopoietic stem cells.
- CDK6: an attractive therapeutic target for T-ALL/LBL.
Most Relevant Clinical Trials
- Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Enc…
- Testing Palbociclib (PD-0332991) as Potentially Targeting Treatment in Cancers With CDK4 or CDK6 Amp…
- Evaluation of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Can…
- Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplast…
- Study to Assess GTAEXS617 in Patients With Advanced Solid Tumors
